Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer

Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer

US Patent 6218529 · Granted Apr 17, 2001

Estimated economic value: $2,132,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Amide linkages of sugar moieties to amine terminated leashes attached to carbohy2025
CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payload2025
Altering net charge on mannosylated dextrans to maximize target tissue uptake an2024
Compounds and methods for diagnosis and treatment of viral infections2024
CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payload2024
Synthesis of uniformly defined molecular weight mannosylated dextrans and deriva2024
Altering net charge on mannosylated dextrans to maximize target tissue uptake an2023
Compositions and methods for altering macrophage phenotype2023
Compounds and methods for diagnosis and treatment of viral infections2021
Methods of detecting influenza virus2019
Combined type angle head milling cutter for machining mounting faces of axial be2018
Prostate-specific gene for diagnosis, prognosis and management of prostate cance2011